MJ Stocks Analysis

[oystersnbeer]

U.S. Food and Drug Administration (FDA) apparently agreed that CBD is the way to go and they've approved clinical trials using the compound. This landmark approval involves the use of a cannabis-based drug and its effects on epilepsy, and could very well change the face of the industry. it wasn't until CNN's chief medical correspondent, Dr. Sanjay Gupta, released his documentary, "Weed," that the compound seemed to gain real momentum as the key to the drug's success. the FDA's approval of these clinical trials could ramp up research industry wide. In the announcement, the FDA said, there are around 60 known chemicals contained in cannabis called cannabinoids. Tetrahydrocannabinol (THC) is the main component responsible for the psychoactive nature of most varieties of cannabis. CBD, however, is the second most abundant cannabinoid in the cannabis and provides medicinal benefits without the "high." These trials could very well open the floodgates to more FDA approvals using CBD as the basis for developing treatments for a number of different ailments.